We are live on ! Find out more
GHSI

Guardion Health Sciences, Inc. Common Stock
GHSI

Delisted

GHSI was delisted on the 11th of October, 2024.

Back to rankings

14 hedge funds and large institutions have $498K invested in Guardion Health Sciences, Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 3

28% more capital invested

Capital invested by funds: $387K → $498K (+$110K)

8% more funds holding

Funds holding: 13 → 14 (+1)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

Holders
14
Holders Change
+1
Holders Change %
+7.69%
% of All Funds
0.22%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
1
Reduced
1
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$114K
2
Renaissance Technologies
Renaissance Technologies
New York
+$16.2K
3
TRCT
Tower Research Capital (TRC)
New York
+$7.45K
4
Bank of America
Bank of America
North Carolina
+$139
5
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$15

Top Sellers

Rank Fund Capital Flow
1
Barclays
Barclays
United Kingdom
-$1.22K
2
UBS Group
UBS Group
Switzerland
-$335
3
RMA
Roffman Miller Associates
Pennsylvania
-$311
4
IPW
Impact Partnership Wealth
Georgia
-$78
Name Holding Trade Value Shares
Change 		Change in
Stake
Renaissance Technologies
1
Renaissance Technologies
New York
$293K +$16.2K +2,100 +6%
Vanguard Group
2
Vanguard Group
Pennsylvania
$110K +$114K +14,852 New
BlackRock
3
BlackRock
New York
$74K – – –
TRCT
4
Tower Research Capital (TRC)
New York
$7.14K +$7.45K +967 New
Barclays
5
Barclays
United Kingdom
$5.48K -$1.22K -158 -18%
Morgan Stanley
6
Morgan Stanley
New York
$4.86K – – –
Citigroup
7
Citigroup
New York
$2.78K – – –
CPG
8
Cornerstone Planning Group
New Jersey
$273 – – –
S
9
SignatureFD
Georgia
$148 – – –
Bank of America
10
Bank of America
North Carolina
$133 +$139 +18 New
FDCDDQ
11
Federation des caisses Desjardins du Quebec
Quebec, Canada
$125 – – –
Wells Fargo
12
Wells Fargo
California
$66 – – –
Osaic Holdings
13
Osaic Holdings
Arizona
$44 – – –
UBS Group
14
UBS Group
Switzerland
– -$335 -43 Closed
RMA
15
Roffman Miller Associates
Pennsylvania
– -$311 -40 Closed
IPW
16
Impact Partnership Wealth
Georgia
– -$78 -10 Closed
Royal Bank of Canada
17
Royal Bank of Canada
Ontario, Canada
– +$15 +2 New

GHSI Hedge Fund Activity: Q3 2023 in Review

14 of the 6,303 institutional investors tracked by Wall St. Rank reported a position in Guardion Health Sciences, Inc. Common Stock (GHSI) for Q3 2023, worth a combined $498K — up 28% from $387K a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new GHSI positions and 3 closed out — a net gain of 1 holder — while 1 added to existing stakes and 1 trimmed.

The largest buyer was Vanguard Group, opening a new position worth an estimated $114K. The largest seller was Barclays, cutting an estimated $1.22K.

  • 14 institutional investors held Guardion Health Sciences, Inc. Common Stock (GHSI) as of Q3 2023, up from 13 in Q2 2023.
  • Funds reported $498K of Guardion Health Sciences, Inc. Common Stock stock for Q3 2023, up 28% quarter-over-quarter.
  • 4 funds opened new Guardion Health Sciences, Inc. Common Stock positions in Q3 2023 and 3 closed out, a net change of +1 holder.
  • The largest Guardion Health Sciences, Inc. Common Stock buyer in Q3 2023 was Vanguard Group, an estimated $114K added.
  • The largest Guardion Health Sciences, Inc. Common Stock seller in Q3 2023 was Barclays, an estimated $1.22K sold.

Based on aggregated 13F filings for Q3 2023.